Literature DB >> 11516998

Disease model: familial adenomatous polyposis.

R Fodde1, R Smits.   

Abstract

Mutations in the APC gene are responsible for familial adenomatous polyposis (FAP) and for the majority of sporadic colorectal cancers. The establishment of genotype-phenotype correlations in FAP is often complicated by the great clinical variability observed among carriers of the same APC mutation even within the same kindred. This variability is likely to arise from the interaction of genetic and environmental modifying factors, the dissection of which ideally requires the employment of mouse models where the effects of specific Apc mutations are analyzed in an inbred, homogeneous genetic background and a controlled environment. The availability of different Apc mouse models allows not only the establishment of more precise genotype-phenotype correlations but has also provided very important clues for the understanding of the function of APC in homeostasis and tumorigenesis. Also, the close phenotypic resemblance to the human disease makes these mice unique preclinical models to test chemopreventive and therapeutic interventions.

Entities:  

Mesh:

Year:  2001        PMID: 11516998     DOI: 10.1016/s1471-4914(01)02050-0

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  30 in total

Review 1.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Immunolocalization of protein 4.1B in the rat digestive system.

Authors:  Nobuo Terada; Nobuhiko Ohno; Hisashi Yamakawa; Takeshi Baba; Yasuhisa Fujii; Osamu Ohara; Shinichi Ohno
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

3.  Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human.

Authors:  Paola Alberici; Emma de Pater; Joana Cardoso; Mieke Bevelander; Lia Molenaar; Jos Jonkers; Riccardo Fodde
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.

Authors:  Richard C Crist; Jacquelyn J Roth; Michael P Lisanti; Linda D Siracusa; Arthur M Buchberg
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

5.  A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.

Authors:  Timothy K Starr; Patricia M Scott; Benjamin M Marsh; Lei Zhao; Bich L N Than; M Gerard O'Sullivan; Aaron L Sarver; Adam J Dupuy; David A Largaespada; Robert T Cormier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

6.  Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.

Authors:  Nobuhiko Ohno; Nobuo Terada; Shin-ichi Murata; Hisashi Yamakawa; Irene F Newsham; Ryohei Katoh; Osamu Ohara; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2004-10-29       Impact factor: 4.304

Review 7.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

8.  Hybrid embryonic stem cell-derived tetraploid mice show apparently normal morphological, physiological, and neurological characteristics.

Authors:  Frieder Schwenk; Branko Zevnik; Jens Brüning; Mathias Röhl; Antje Willuweit; Anja Rode; Thomas Hennek; Gunther Kauselmann; Rudolf Jaenisch; Ralf Kühn
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

9.  Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.

Authors:  Claudia Gaspar; Joana Cardoso; Patrick Franken; Lia Molenaar; Hans Morreau; Gabriela Möslein; Julian Sampson; Judith M Boer; Renée X de Menezes; Riccardo Fodde
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

10.  Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.

Authors:  Suniti Misra; Vincent C Hascall; Carla De Giovanni; Roger R Markwald; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.